Trademarkia Logo

Australia

AU$
ONCYTIQ
Ceased - Not renewed: Renewal fee not paid

Last updated on 9 May 2024

Owner Info

Sunesis Pharmaceuticals, Inc.

395 Oyster Point Blvd., Suite 400

South San Francisco CA 94080, UNITED STATES OF AMERICA

Serial Number

1591252 filed on 17 Oct 2013

Correspondent

Harold Milstein Sheppard Mullin Richter & Hampton LLP

379 Lytton Avenue,

Palo Alto CA 94301,

UNITED STATES OF AMERICA

ONCYTIQ

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of tumors, cancers, hematological disorders and hematological malignancies

Mark Details


Serial Number

1591252

Registered On

17 Oct 2013

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

19 Apr 2013

Mark Type

US

Legal History


Show more

Status DateAction Taken
9th May 2024Status change to Removed/Ceased - Not Renewed
20th Feb 2014IP Right Registration Published
13th Feb 2014Register Trade Mark
13th Feb 2014Application Status
5th Dec 2013IP Right Acceptance Published
28th Nov 2013Clear Examination report approved
28th Nov 2013Application Accepted correspondence sent
21st Nov 2013IP Right Filed Published
15th Nov 2013Application Status
15th Nov 2013Application Status